Wehrli Martina, Hensler Stefanie, Schindele Stephan, Herren Daniel B, Marks Miriam
Department of Teaching, Research and Development, Schulthess Clinic, Zurich, Switzerland; Zurich University of Applied Sciences, School of Health Professions, Institute of Physiotherapy, Winterthur, Switzerland.
Department of Teaching, Research and Development, Schulthess Clinic, Zurich, Switzerland.
J Hand Surg Am. 2016 Sep;41(9):896-902. doi: 10.1016/j.jhsa.2016.06.009. Epub 2016 Jul 26.
The brief Michigan Hand Outcomes Questionnaire (briefMHQ) was developed as a shorter version of the Michigan Hand Outcomes Questionnaire (MHQ), but its measurement properties have not been investigated in patients with Dupuytren contracture. The objective of the study was to investigate the reliability, validity, responsiveness, and interpretability of the briefMHQ.
Fifty-seven patients diagnosed with Dupuytren contracture completed the briefMHQ as well as the full-length MHQ and Quick Disabilities of the Arm, Shoulder, and Hand (QuickDASH) questionnaire at baseline. Two to 14 days after baseline and 1 year after collagenase injection or surgery, patients again filled out the briefMHQ. Reliability was determined using the intraclass correlation coefficient and by calculating internal consistency (Cronbach alpha). Validity was tested by quantifying correlations with the full-length MHQ and QuickDASH. Responsiveness, based on the standardized response mean and the minimally clinically important change, was also determined.
The briefMHQ had an intraclass correlation coefficient of 0.87, Cronbach alpha of 0.88, and correlations of r = 0.88 and -0.82 with the original MHQ and QuickDASH, respectively. The standardized response mean was 0.9 and the minimally clinically important change was 7 points.
Overall, the briefMHQ demonstrates excellent reliability, good validity, and high responsiveness in patients with Dupuytren contracture.
The briefMHQ is an accurate and time-saving tool to evaluate patients with Dupuytren contracture and the effect of a corresponding treatment.
简短版密歇根手部结果问卷(briefMHQ)是作为密歇根手部结果问卷(MHQ)的较短版本开发的,但尚未在掌腱膜挛缩症患者中对其测量特性进行研究。本研究的目的是调查briefMHQ的可靠性、有效性、反应性和可解释性。
57例诊断为掌腱膜挛缩症的患者在基线时完成了briefMHQ以及全长MHQ和手臂、肩部和手部快速残疾问卷(QuickDASH)。在基线后2至14天以及胶原酶注射或手术后1年,患者再次填写briefMHQ。使用组内相关系数并通过计算内部一致性(Cronbachα)来确定可靠性。通过量化与全长MHQ和QuickDASH的相关性来测试有效性。还基于标准化反应均值和最小临床重要变化确定反应性。
briefMHQ的组内相关系数为0.87,Cronbachα为0.88,与原始MHQ和QuickDASH的相关性分别为r = 0.88和 - 0.82。标准化反应均值为0.9,最小临床重要变化为7分。
总体而言,briefMHQ在掌腱膜挛缩症患者中表现出优异的可靠性、良好的有效性和高反应性。
briefMHQ是一种准确且省时的工具,可用于评估掌腱膜挛缩症患者及相应治疗的效果。